https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1065279/vaccine-surveillance-report-week-13.pdf Page 4: The propaganda - Large clinical trials have been undertaken for each of the COVID-19 vaccines approved in the UK which found that they are highly efficacious at preventing symptomatic disease in the populations that were studied. The clinical trials have been designed to be able to assess the efficacy of the vaccine against laboratory confirmed symptomatic disease with a relatively short follow up period so that effective vaccines can be introduced as rapidly as possible. Page 43: Death within 60 days of positive COVID-19 test by date of death between week 9 2022 (w/e 6 March 2022) and week 12 2022 (w/e 27 March 2022) under 18 unvaccinated = 2 - boosted = 0 18 to 29 unvaccinated = 6 - boosted = 5 30 to 39 unvaccinated = 13 - boosted = 17 40 to 49 unvaccinated = 11 - boosted = 29 50 to 59 unvaccinated = 24 - boosted = 78 60 to 69 unvaccinated = 48 - boosted = 208 70 to 79 unvaccinated = 72 - boosted = 611 80 and over unvaccinated = 145 - boosted = 2,106 unvaccinated = 321 - boosted = 3,054 - that's a ratio of 9.5 to 1.